The HAG Insight consortium (Head of Agencies Group Initiative for Knowledge and Skill Enhancement in Health Technology Assessment Regulation) has just signed a service contract with the European Health and Digital Executive Agency (HaDEA) to strengthen the long-term capacity and expertise of EU HTA bodies in executing the HTAR effectively and in a sustainable manner in view of the upcoming health technology scope expansions.

Building on extensive preparations during the last 3 years, the project will establish a comprehensive HTAR training platform on procedures and methods with latest insights for the HTA bodies and a selected representation of other stakeholders.
The consortium of leading EU HTA bodies will deliver the project, each bringing their expertise to ensure high-impact training. AGENAS will act as a coordinator, facilitated by Director Dr. Marco Marchetti who brings his experience of over 20 years in executing global HTA workforce development programs and projects.
Funded by HaDEA with the support of DG SANTE under the EU4Health European Union’s programme, the HAG Insight consortium is committed to fostering the sustainable growth of a skilled and resilient HTA community across the EU, equipped with the right tools to effectively assess health technologies and address future challenges in European healthcare for decades to come.

The consortium

  • Agenzia Nazionale per I Servizi Sanitari Regionali (‘AGENAS’)
  • Haute Autorité de Santé (‘HAS’)
  • Austrian Institute for Health Technology Assessment GmbH (‘AIHTA’)
  • Υπουργείο Υγείας της Ελλάδας (Ministry of Health of Greece)
  • St James Hospital Board
  • Health Information and Quality Authority (‘HIQA’)
  • Norwegian Medical Products Agency (‘NOMA’)
  • Zorginstituut Nederland (‘ZIN’)
  • Autoridade Nacional do Medicamento e Produtos da Saude IP (‘INFARMED’)
  • Agencia de Qualitat i Avaluacio Sanitaries de Catalunya (‘AQuAS’)
  • Fundacion Canaria Instituto de Investigacion Sanitaria de Canarias (‘FIISC-SECS’)
  • Agencia Española de Medicamentos y Productos Sanitarios (‘AEMPS’)
  • Tandvårds-och läkemedelsförmånsverket (‘TLV’)
  • Fundacion Publica Andaluza Progreso y Salud M.P. (‘FPS’)
  • Ministrstvo za zdravje slovenije (Ministry of health of Slovenia)
With the support of:
  • GmbH Institute for Quality and Efficiency in Health Care (‘IQWIG’)
  • Federal Joint Committee (‘G-BA’)
External subcontractors
  • Università Cattolica del Sacro Cuore
  • University of Utrecht
  • Deloitte consulting Italy
  • Deloitte risk advisory Italy

 

 

Visite: 250

Torna su